The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan

This analysis estimates the economic and clinical impact of a Moderna updated COVID-19 mRNA Fall 2023 vaccine for adults ≥18 years in Japan. A previously developed Susceptible-Exposed-Infected-Recovered (SEIR) model with a one-year analytic time horizon (September 2023–August 2024) and consequences...

Full description

Bibliographic Details
Published in:Vaccines
Main Authors: Kelly Fust, Keya Joshi, Ekkehard Beck, Michael Maschio, Michele Kohli, Amy Lee, Yuriko Hagiwara, Nicolas Van de Velde, Ataru Igarashi
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Subjects:
coronavirus
SARS-CoV-2
Japan
COVID-19
vaccination
cost-effectiveness
Online Access:https://www.mdpi.com/2076-393X/12/4/434

Internet

https://www.mdpi.com/2076-393X/12/4/434

Similar Items